Literature DB >> 15359636

Distribution and prognosis of WHO lymphoma subtypes in Taiwan reveals a low incidence of germinal-center derived tumors.

Kong-Chao Chang1, Guan-Cheng Huang, Dan Jones, Chao-Jung Tsao, J Yu-yun Lee, Ih-Jen Su.   

Abstract

To assess the distribution of lymphomas in Taiwan according to the WHO (World Health Organization) classification, 175 recently diagnosed cases of malignant lymphomas were studied and the clinicopathologic data were analyzed. B-cell lymphomas accounted for 57.1% of cases, T-cell lymphomas 38.9%, and Hodgkin's lymphoma 4%. Extranodal lymphomas predominated (55.4%). The most common subtype of B-cell lymphoma was diffuse large B-cell lymphoma (33.1%). All tumor types believed to be derived from germinal center (GC) B-cells including follicular lymphoma (4.6%), Burkitt lymphoma (1.7%), Hodgkin lymphoma (4.0%), and GC-like diffuse large B-cell lymphoma (as defined by combined expression of bc1-6 and CD10) were rather uncommon as compared to frequencies seen in series from Western countries. The common T-cell lymphomas included nasal and extranasal NK/T cell lymphoma (7.4%), mycosis fungoides (7.4%), and unspecified peripheral T-cell lymphoma (6.9%). Adult T-cell leukemia/lymphoma was very uncommon and accounts for only 0.6%. The proportional increase in T-cell lymphomas that were unrelated to type I human T-cell lymphotropic virus (HTLV-1) may be linked to differential Epstein-Barr virus (EBV) oncogenesis. The survival data revealed that mantle cell lymphoma, NK/T-cell lymphoma, unspecified peripheral T-cell lymphoma, and subcutaneous panniculitis-like T-cell lymphoma had an aggressive course. Our results confirm the utility of the WHO classification scheme for prognostic stratification and further highlight the distinctive distribution pattern of malignant lymphoma in Taiwan including the higher relative incidence of T cell lymphomas and the rarity of germinal center-derived B-cell tumors.

Entities:  

Mesh:

Year:  2004        PMID: 15359636     DOI: 10.1080/10428194042000198849

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  7 in total

1.  Angioimmunoblastic T-cell lymphoma in Taiwan shows a frequent gain of ITK gene.

Authors:  Peir-In Liang; Sheng-Tsung Chang; Ming-Yen Lin; Yen-Chuan Hsieh; Pei-Yi Chu; Chih-Jung Chen; Kai-Jen Lin; Yun-Chih Jung; Wei-Shou Hwang; Wen-Tsung Huang; Wei-Chin Chang; Hongtao Ye; Shih-Sung Chuang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 2.  An Update on the Pathology and Molecular Features of Hodgkin Lymphoma.

Authors:  Akira Satou; Taishi Takahara; Shigeo Nakamura
Journal:  Cancers (Basel)       Date:  2022-05-26       Impact factor: 6.575

Review 3.  Hodgkin lymphoma: an update on its biology with new insights into classification.

Authors:  Haresh Mani; Elaine S Jaffe
Journal:  Clin Lymphoma Myeloma       Date:  2009-06

Review 4.  Interplay between Epstein-Barr virus infection and environmental xenobiotic exposure in cancer.

Authors:  Francisco Aguayo; Enrique Boccardo; Alejandro Corvalán; Gloria M Calaf; Rancés Blanco
Journal:  Infect Agent Cancer       Date:  2021-06-30       Impact factor: 2.965

5.  Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma.

Authors:  Kung-Chao Chang; Wei-Chao Chang; Yao Chang; Liang-Yi Hung; Chien-Hsien Lai; Yu-Min Yeh; Yu-Wei Chou; Chung-Hsuan Chen
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

6.  Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma.

Authors:  Nada E Hammouda; Manal A Salah El-Din; Mamdouh M El-Shishtawy; Amal M El-Gayar
Journal:  Sci Pharm       Date:  2017-03-08

Review 7.  Non-mycosis fungoides cutaneous lymphomas in a referral center in Taiwan: A retrospective case series and literature review.

Authors:  Kwei-Lan Liu; Wen-Chien Tsai; Chih-Hung Lee
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.